CORZ PE Ratio & Valuation,Is CORZ Overvalued

CORZ Relative Valuation

CORZ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CORZ is overvalued; if below, it's undervalued.

Historical Valuation

Core Scientific Inc (CORZ) is now in the Fair zone, suggesting that its current forward PS ratio of 7.41 is considered Fairly compared with the five-year average of -147.45. The fair price of Core Scientific Inc (CORZ) is between 9.69 to 18.69 according to relative valuation methord.

Relative Value

Fair Zone

9.69-18.69

Current Price：16.70

Fair

-74.89

22.23

EV/EBITDA

Core Scientific Inc. (CORZ) has a current EV/EBITDA of 22.23. The 5-year average EV/EBITDA is 17.43. The thresholds are as follows: Strongly Undervalued below 5.49, Undervalued between 5.49 and 11.46, Fairly Valued between 23.41 and 11.46, Overvalued between 23.41 and 29.38, and Strongly Overvalued above 29.38. The current Forward EV/EBITDA of 22.23 falls within the Historic Trend Line -Fairly Valued range.

-103.07

EV/EBIT

Core Scientific Inc. (CORZ) has a current EV/EBIT of -103.07. The 5-year average EV/EBIT is 10.21. The thresholds are as follows: Strongly Undervalued below -221.94, Undervalued between -221.94 and -105.87, Fairly Valued between 126.28 and -105.87, Overvalued between 126.28 and 242.36, and Strongly Overvalued above 242.36. The current Forward EV/EBIT of -103.07 falls within the Historic Trend Line -Fairly Valued range.

7.41

Core Scientific Inc. (CORZ) has a current PS of 7.41. The 5-year average PS is 5.39. The thresholds are as follows: Strongly Undervalued below 0.40, Undervalued between 0.40 and 2.90, Fairly Valued between 7.89 and 2.90, Overvalued between 7.89 and 10.38, and Strongly Overvalued above 10.38. The current Forward PS of 7.41 falls within the Historic Trend Line -Fairly Valued range.

21.85

P/OCF

Core Scientific Inc. (CORZ) has a current P/OCF of 21.85. The 5-year average P/OCF is 16.00. The thresholds are as follows: Strongly Undervalued below 0.86, Undervalued between 0.86 and 8.43, Fairly Valued between 23.57 and 8.43, Overvalued between 23.57 and 31.14, and Strongly Overvalued above 31.14. The current Forward P/OCF of 21.85 falls within the Historic Trend Line -Fairly Valued range.

57.11

P/FCF

Core Scientific Inc. (CORZ) has a current P/FCF of 57.11. The 5-year average P/FCF is -0.97. The thresholds are as follows: Strongly Undervalued below -105.24, Undervalued between -105.24 and -53.11, Fairly Valued between 51.16 and -53.11, Overvalued between 51.16 and 103.30, and Strongly Overvalued above 103.30. The current Forward P/FCF of 57.11 falls within the Overvalued range.

Core Scientific Inc (CORZ) has a current Price-to-Book (P/B) ratio of -4.37. Compared to its 3-year average P/B ratio of -4.99 , the current P/B ratio is approximately -12.35% higher. Relative to its 5-year average P/B ratio of -4.99, the current P/B ratio is about -12.35% higher. Core Scientific Inc (CORZ) has a Forward Free Cash Flow (FCF) yield of approximately -6.94%. Compared to its 3-year average FCF yield of -1.22%, the current FCF yield is approximately 468.94% lower. Relative to its 5-year average FCF yield of -1.22% , the current FCF yield is about 468.94% lower.

-4.37

P/B

Median3y

-4.99

Median5y

-4.99

-6.94

FCF Yield

Median3y

-1.22

Median5y

-1.22

Competitors Valuation Multiple

The average P/S ratio for CORZ's competitors is 8.61, providing a benchmark for relative valuation. Core Scientific Inc Corp (CORZ) exhibits a P/S ratio of 7.41, which is -13.96% above the industry average. Given its robust revenue growth of -14.95%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of CORZ increased by 32.36% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -3.55 to -7.43.

The secondary factor is the Revenue Growth, contributed -14.95%to the performance.

Overall, the performance of CORZ in the past 1 year is driven by P/E Change. Which is more unsustainable.

-14.95%

95.35M → 81.10M

Revenue Growth

-62.13%

-477.44 → -180.83

Margin Expansion

109.44%

-3.55 → -7.43

P/E Change

32.36%

12.27 → 16.24

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Core Scientific Inc (CORZ) currently overvalued or undervalued?

What is Core Scientific Inc (CORZ) fair value?

CORZ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Core Scientific Inc (CORZ) is between 9.69 to 18.69 according to relative valuation methord.

How does CORZ's valuation metrics compare to the industry average?

What is the current P/B ratio for Core Scientific Inc (CORZ) as of Jan 09 2026?

As of Jan 09 2026, Core Scientific Inc (CORZ) has a P/B ratio of -4.37. This indicates that the market values CORZ at -4.37 times its book value.

What is the current FCF Yield for Core Scientific Inc (CORZ) as of Jan 09 2026?

As of Jan 09 2026, Core Scientific Inc (CORZ) has a FCF Yield of -6.94%. This means that for every dollar of Core Scientific Inc’s market capitalization, the company generates -6.94 cents in free cash flow.

What is the current Forward P/E ratio for Core Scientific Inc (CORZ) as of Jan 09 2026?

As of Jan 09 2026, Core Scientific Inc (CORZ) has a Forward P/E ratio of -74.89. This means the market is willing to pay $-74.89 for every dollar of Core Scientific Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Core Scientific Inc (CORZ) as of Jan 09 2026?

As of Jan 09 2026, Core Scientific Inc (CORZ) has a Forward P/S ratio of 7.41. This means the market is valuing CORZ at $7.41 for every dollar of expected revenue over the next 12 months.

CORZ Valuation